Ginger for Visceral Fat: Evidence and Safety

Ginger for visceral fat is a topic attracting growing interest as researchers explore how dietary compounds might support weight management. Visceral fat, the deep abdominal fat surrounding internal organs, is strongly linked to type 2 diabetes, cardiovascular disease and metabolic syndrome, making it a priority target for lifestyle intervention. Ginger (Zingiber officinale) contains bioactive compounds called gingerols and shogaols, which may influence fat metabolism, inflammation and insulin sensitivity. This article examines what the current evidence shows, how ginger might work, whether food or supplements are more effective, and how to use ginger safely alongside NHS weight management advice.

What is visceral fat and why does it matter for your health?

Visceral fat is metabolically active fat stored deep in the abdominal cavity, strongly associated with insulin resistance, type 2 diabetes and cardiovascular disease. NICE recognises central adiposity as a key risk marker, using waist circumference thresholds that vary by sex and ethnicity.

Visceral fat is the metabolically active fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it carries greater health risks than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at the waist, visceral fat is not visible from the outside, yet it is strongly associated with insulin resistance, raised blood pressure, dyslipidaemia and an increased risk of type 2 diabetes and cardiovascular disease.

The NHS and NICE both recognise central adiposity as a key risk marker. Waist circumference is a practical proxy. In White and Black populations, NICE guidance identifies increased risk at waist measurements above 94 cm in men and above 80 cm in women, with substantially higher risk above 102 cm and 88 cm respectively. Lower thresholds apply for South Asian, Chinese and other higher-risk ethnic groups, where increased risk begins at 90 cm in men and 80 cm in women.^[1] Your GP can advise on the thresholds most appropriate for you, taking ethnicity and other risk factors into account.

Visceral fat is biologically active, releasing inflammatory cytokines and free fatty acids directly into the portal circulation, which reaches the liver first. This contributes to non-alcoholic fatty liver disease and systemic low-grade inflammation. Because visceral fat responds to lifestyle change, including dietary modification and increased physical activity, it is an important and modifiable target in weight management. Understanding what influences visceral fat accumulation is therefore clinically relevant, and it is in this context that interest in dietary compounds such as ginger has grown.

What does the evidence say about ginger and visceral fat?

Current evidence suggests ginger supplementation may modestly reduce waist circumference and body fat percentage, but effect sizes are small and evidence quality is low to moderate. Most trials did not directly measure visceral fat volume using imaging.

The current evidence suggests that ginger supplementation may modestly reduce markers of central adiposity, including waist circumference and body fat percentage, but the data are not yet strong enough to support firm clinical recommendations. Most of the available research consists of small randomised controlled trials and meta-analyses of those trials, with significant variation in study populations, doses, formulations and duration.

A 2019 meta-analysis published in Critical Reviews in Food Science and Nutrition pooled data from several trials and found that ginger supplementation was associated with statistically significant reductions in body weight, waist-to-hip ratio and fasting glucose compared with placebo. However, the absolute effect sizes were modest, and the authors noted considerable heterogeneity between studies. Importantly, most trials did not use imaging techniques such as MRI or CT to directly measure visceral fat volume, relying instead on anthropometric proxies such as waist circumference.

A smaller number of trials have used more precise measurement methods and have reported reductions in visceral fat area in participants with obesity or metabolic syndrome following ginger supplementation over periods of eight to twelve weeks, though sample sizes have generally been small. The overall quality of the evidence base, assessed using standard appraisal frameworks, is considered low to moderate, reflecting these limitations.

In summary, ginger shows biological plausibility and some promising signals in early research, but it should not be positioned as a standalone treatment for visceral fat. It is best considered a potential adjunct to established lifestyle interventions rather than a replacement for them.

How might ginger work to reduce fat around the organs?

Gingerols and shogaols may reduce visceral fat through thermogenesis, inhibition of lipogenesis, promotion of lipolysis and reduction of inflammatory cytokines. Most mechanistic evidence comes from cell and animal studies, so findings should be interpreted cautiously.

Ginger (Zingiber officinale) contains several bioactive compounds, most notably gingerols and shogaols, which are thought to influence fat metabolism through multiple complementary mechanisms. These compounds are not a single drug with a single target but a complex mixture with overlapping actions.

One proposed mechanism involves thermogenesis: gingerols and shogaols may activate transient receptor potential vanilloid (TRPV1) channels, increasing heat production and energy expenditure in a manner broadly similar to capsaicin from chilli peppers.^[6] This could, in theory, contribute to a modest increase in calorie burning over time.

A second mechanism relates to lipid metabolism. Preclinical studies suggest that ginger compounds may inhibit lipogenesis (the synthesis of new fat) and promote lipolysis (the breakdown of stored fat), partly through effects on peroxisome proliferator-activated receptors (PPARs) and AMP-activated protein kinase (AMPK), both of which are important regulators of fat storage and energy balance.^[6]

Ginger also has well-documented anti-inflammatory properties. Because visceral fat is characterised by chronic low-grade inflammation, reducing inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) may help break the cycle of metabolic dysfunction. Additionally, some evidence points to ginger improving insulin sensitivity, which could reduce the tendency to store excess energy as visceral fat.

It is important to note that most mechanistic evidence comes from cell culture and animal studies. Translating these findings to humans requires caution, and the doses used in laboratory settings often exceed what is achievable through diet or standard supplementation. The European Medicines Agency's Committee on Herbal Medicinal Products (HMPC) has published a community herbal monograph for Zingiber officinale rhizoma, which provides a useful authoritative summary of the evidence base for ginger-containing herbal products.^[5][6]

Can you get enough active compounds from food or do you need supplements?

Dietary ginger is unlikely to deliver the 1 g to 3 g daily doses used in trials; standardised supplements provide more consistent amounts of active compounds. Choose products with clearly stated gingerol content, or those holding an MHRA Traditional Herbal Registration for greater quality assurance.

The doses of ginger used in clinical trials that showed metabolic effects typically ranged from 1 g to 3 g of dried ginger powder or extract per day.^[4][6] This is considerably higher than the amount most people consume through cooking or drinks. A typical portion of fresh ginger used in a meal or a cup of ginger tea is unlikely to deliver the quantities of gingerols or shogaols studied in trials, meaning that dietary intake alone is unlikely to replicate the doses used in research.

Dried ginger powder, ginger capsules and standardised extracts are available as food supplements in the UK. These are regulated as food supplements under UK food law, overseen by the Food Standards Agency (FSA) and enforced by local Trading Standards authorities, rather than assessed for efficacy by the MHRA before sale.^[7] Quality, potency and bioavailability can vary considerably between products, and there is no requirement for manufacturers to demonstrate that their product delivers a clinically meaningful dose of gingerols or shogaols.

If you are considering a ginger supplement, look for products that clearly state the quantity of active compounds (such as gingerols) per dose, rather than simply listing the weight of ginger powder. Choosing reputable manufacturers with clear standardisation labelling provides greater confidence in what you are taking. Where ginger is used as a traditional herbal medicine rather than a food supplement, it may hold an MHRA Traditional Herbal Registration (THR), which indicates that the product has met standards for quality and traditional use, though not for efficacy in the clinical sense.^[8][9]

For most people, incorporating ginger regularly into a varied, balanced diet remains a safe and enjoyable approach, even if the metabolic effects are likely to be smaller than those seen in supplementation trials. Ginger should complement, not replace, evidence-based dietary advice from a registered dietitian or healthcare professional.

Is ginger safe to use alongside NHS weight management advice?

Ginger is generally well tolerated but can enhance the blood-thinning effect of warfarin and may increase hypoglycaemia risk with antidiabetic medicines. Always discuss ginger supplements with your GP or pharmacist before use, especially if taking prescribed medicines.

Ginger is generally well tolerated at culinary doses and at the supplementation doses used in most clinical trials, but there are important safety considerations to be aware of before using it alongside NHS weight management programmes or prescribed medicines. The most commonly reported side effects include heartburn, bloating, nausea and mild gastrointestinal discomfort, particularly at higher doses.

The most clinically significant interaction is with anticoagulant medicines, particularly warfarin. Ginger has antiplatelet properties and may enhance the blood-thinning effect of warfarin, potentially affecting INR control and increasing the risk of bleeding.^[5][6] This caution also extends to antiplatelet medicines such as aspirin and clopidogrel. If you are taking warfarin, any other anticoagulant, or an antiplatelet medicine, you should speak to your GP or pharmacist before taking ginger supplements. Ginger may also have additive effects with antidiabetic medicines, potentially increasing the risk of hypoglycaemia, so monitoring is advisable if you are on such treatment.^[12][5]

Ginger supplements are not recommended during pregnancy or breastfeeding without medical advice. High doses have historically been associated with concerns about uterine stimulation during pregnancy, and there is insufficient evidence to confirm safety during breastfeeding.^[11] People with gallstones should also seek medical advice before use, as ginger may stimulate bile production.^[5][6]

For those following NHS Tier 3 or Tier 4 weight management services, or taking MHRA-authorised weight management medicines, ginger should be discussed with the clinical team as part of a full medicines review. If you experience any unexpected symptoms after starting a ginger supplement, contact your GP in the first instance. Suspected adverse reactions to food supplements can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Bolt Pharmacy is a GPhC-registered online pharmacy (GPhC regulates pharmacies in Great Britain; pharmacies in Northern Ireland are regulated by the PSNI) offering online weight-management consultations, with prescriber review and pharmacist support. Weight management medicines are only prescribed where clinically appropriate following a consultation.

Scientific References

1. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
2. Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev. 2012..
3. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte. 2015..
4. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019..
5. Community herbal monograph on Zingiber officinale Roscoe, rhizoma.
6. Assessment report on Zingiber officinale Roscoe, rhizoma.
7. Nutrition legislation information sheet.
8. Apply for a traditional herbal registration (THR).
9. Herbal medicines granted a traditional herbal registration (THR).
10. Antioxidant and anti-inflammatory effects of ginger supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomised controlled trials. Inflammopharmacology. 2025..
11. Statement on the safety of ginger supplement use in pregnancy.
12. The efficacy and safety of herbal medicines for glycaemic control and insulin resistance in individuals with type 2 diabetes: an umbrella review. BMC Complement Med Ther. 2024..

Frequently Asked Questions